title: Balancing the risks and benefits for pioglitazone in type 2 diabetes.
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Johnson
authors.forename: Isabelle N
authors.initials: IN
authors.lastname: Colmers
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008297:Male; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone